Dr. Augusto Villa is one of the Top Cardiovascular Doctors in America, per Castle Connolly Medical Ltd., America”s trusted source for identifying the Best Top Doctors in American Medicine. He has successfully performed more than 12,000 coronary and peripheral vascular diagnostic and interventional procedures throughout his career.

Dr. Villa’s elective cardiovascular procedures hospital mortality rate is Zero.

He moved to the Palm Beaches 15 years ago from Cleveland, Ohio, where he received training in Interventional Cardiology at the world renowned Cleveland Clinic.

Dr. Villa is Chief of Interventional Cardiology and Director of the Vascular and Vein Center at The Palm Beach Cardiovascular Clinic. He also serves as Chairman of Cardiology committee at Jupiter Medical Center, Jupiter, Florida.

In addition to his stellar academic training and his vast experience as a Cardiologist in Palm Beach Gardens and Jupiter, FL, Dr. Villa prides himself on his sincere desire to help others. His passion for saving lives through all these years, have pushed him to the frontier of success in the prevention of heart diseases and Interventional Cardiology Procedures.

Medical Education

Dr. Villa received his medical education at the Universidad Cayetano Heredia in Lima, Peru and from Johns Hopkins University School of Medicine in Baltimore, Maryland.

Residency and Fellowship

• 2-year Interventional Cardiology Fellowship at The Cleveland Clinic Foundation, Cleveland, Ohio.
• 3-year Cardiology Fellowship at The University of Miami School of Medicine Hospitals, Miami, FL.
• Residency Elective Rotation: Cardiology Consult Service at The Johns Hopkins Hospital, Baltimore, Maryland.
• 3-year Internship and Residency in Internal Medicine at the University of Miami School of Medicine Hospitals, Miami, FL.

Hospital Appointments

• Member, Corporate Board, Jupiter Medical Center, Jupiter, FL.
• Member, Physician Leadership Group, Palm Beach Gardens Medical Center, Palm Beach Gardens, FL.

Board Certifications

If you are looking for a board certified Cardiologist in Palm Beach Gardens or nearby cities, you are looking at the right doctor. If your doctor is certified by an American Board of Medical Specialties (ABMS Member Board), it means he or she is dedicated to providing exceptional patient care through a rigorous, voluntary commitment to lifelong learning through board certification and ABMS Maintenance of Certification (MOC).

Dr. Villa is board certified by the American Board of Internal Medicine in Cardiovascular Diseases, Interventional Cardiology and Internal Medicine. He is also Board certified by the American Board of Vascular Medicine in Endovascular Medicine.

Castle Connolly Top Doctor, Interventional Cardiology, 2011 (Click Here, then enter 33458 for zip code and Interventional Cardiology for specialty).Physician Reported Awards

• Top Interventional Cardiologist , U.S. News and World Report , 2011 (Click Here).
• Patients’ Choice Award Winner for 2012 (Click Here) .
• Top Doctor, Interventional Cardiology, Palm Beach Magazine , 2011 (Click Here).
• Top Doctor, Interventional Cardiology, Jupiter Magazine, 2011 (Click Here)
• Top Doctor, Gulfstream Media Group , 2011.
• Who’s Who America , 2011.

Academic and Administrative Appointments

Dr. Villa has held multiple academic and administrative appointments to include:

• Clinical Professor. University of Texas Health and Science Center at McAllen, Texas.
• Clinical Investigator Associate at the Department of Cardiovascular Medicine. The Cleveland Clinic Foundation, Cleveland, Ohio.
• Clinical Instructor, Department of Medicine. University of Miami School of Medicine.
• Internal Medicine Ward Attending at the University of Miami/V.A. Medical Center.
• Chief of Cardiology Palm Beach Gardens Medical Center (2001-2005).
• Chief of Interventional Cardiology and Director Cardiac Cath. Labs (2005-2007).
• Director, Interventional Cardiology Clinical Trials -Advanced Clinical Research Group, L.L.C. Jupiter and Stuart, FL (2001-now).

Society Memberships

• Fellow American College of Cardiology
• Society of Cardiovascular Angiography and Interventions
• American Heart Association: Clinical Cardiology Council
• Society of Vascular Medicine
• International Society of Endovascular Surgery
• International Society of Cardiovascular Interventionists
• American College of Phlebology
• American College of Physicians

Research

Dr. Villa is the Principal Investigator for Multiple Cardiology and Cardiovascular Trials including:

• PLATO (Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes, Principal Investigator, (2006-Present).
• IMPROVE-IT (A Multicenter Study to Establish the Clinical Benefit and Safety of Vytorin vs Simvastatin Monotherapy in High-Risk Subjects Presenting with Acute Coronary Syndrome), Principal Investigator, (2005-Present).
• ARRIVE (TAXUSòŸ’´ent Registry: Multi-Center Safety Surveillance Program), Principal Investigator, (2004-Present).
• TRITON TIMI-38 (A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention), Principal Investigator, (2004-Present).
• SYNERGY (A Prospective, Randomized, Open Label, Multicenter Study In Patients With Acute Coronary Syndromes (ACS) Principal Investigator, (2002-2004).
• STELLAR (Study to Evaluate the Safety and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Subjects With Hypercholesterolemia) Principal Investigator, (2001-2004).
• The IMPACT Study (The Impact of Medical Subspeciality on Patient compliance to Treatment) Principal Investigator (2001).
• TARGET Trial (Multicenter, Double-Blind, Abciximab-Controlled Study to Evaluate the Efficacy of Tirofiban in Patients Undergoing Percutaneous coronary Intervention with Intracoronary Stent Placement) Principal Investigator (2000).
• GUSTO V AMI: (Trial Evaluating the Efficacy and Safety of ReoPro in Combination with Reduced Dose Retavase for the Treatment of Acute Myocardial Infarction), Principal Investigator (1999-2001).
• Coumadin Aspirin Reinfarction Study (CARS) Principal Investigator for the McAllen, Texas Site. (1994-1996).

Publications

1. DeMarchena EJ, Chakko S, Fernandez P, Villa, AE, Thurer R, Kessler K, Myerburg, RJ. Usefulness of the automatic Implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease. Am J Cardiol 1991: 67: 812-816.
2. Villa, AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of Dexamethasone for Prevention of neointimal Proliferation in a Rat Model of Balloon Angioplasty. J Clin Inves 1994; 93: 1243-1249
3. Villa AE, Guzman LA, Poptic E, Labhasetwar V, Dì’¯usa S, Farrell Cl, Plow EF, Levy RJ, DiCorleto P, Topol EJ. The effects of Antisense c-myb Oligonucleotides on Vascular Smooth Muscle Cell Proliferation and Response to Vessel Wall Injury. Circ Research 1995, 76: 505-513.
4. Guzman LA, Forudi F, Villa AE, Topol EJ. Role of leukocytes in neointimal formation after balloon angioplasty in the rabbit atherosclerotic model. Coron Artery Dis, 1995 Sep;6(9):693-701.
5. DeMarchena EJ, Villa AE, Futterman LG, Bauerlein EJ, Booloki H, Horowitz MD, Myerberg RJ, Castellanos A. Paired EKGì± Recorded from the Same Heart in Different Patients: Transplant Donor and Recipient Comparisons. Circulation, 1991; 84: II-614.
6. Villa AE, Franco I, Raymond RE, DeLuca S, Casal PN, Whitlow PL. The use of Atherectomy Devices in Coronary Lesions of Different Morphology and Location. J. Am. Coll Cardiol 1992: 19: 93A.
7. Villa AE, Robalino B, Bedoya L, Valenzuela R, Braun WE. Can T Lymphocytes Subsets be used to Gauge Plaque Activity in Coronary Atherosclerosis? Circulation 1992: 86: I-75.
8. Guzman LA, Villa, AE, Whitlow PL. New Atherectomy Devices in Treatment of Old Saphenous Vein Grafts Are the Initial Results Encouraging? Circulation 1992; 86:I-780.
9. Casale PN, Villa AE, Robalino BD, Salcedo EE. Left Ventricular Hypertrophy Increases the Risk of Major Complications during Elective PTCA. Circulation 1992: 86:I-786.
10. Villa AE, Guzman LA, Golomb G, Levy RJ, Topol EJ. Local Delivery of Dexamethasone for Prevention of Neointimal Proliferation after Balloon Injury in the Rat Carotid Model. J Am Coll Cardiol. 1993; 21:179A.
11. Guzman La, Villa AE, Golomb G, Levy R, Furst J, Topol EJ. Effect of In-Situ Polymeric Hirulog Release on Restenosis Following Balloon Angioplasty in the Atherosclerotic Rabbit. J Am Coll Cardiol 1993; 21: 185A.
12. Villa AE, Guzman LA, Casale PN, Whitlow PL. Is Rotational Coronary Atherectomy More Risky in the Right Coronary Artery? Cathet Cardiovasc Diagn 1993; 29:84.
13. Guzman LA, Villa AE, Raymond R, Casale P, Whitlow PL. Does Percutaneous Revascularization with New Atheretomy Devices in the Elderly Population Carry a Higher Risk? Cathet Cardiovasc Diagn 1993; 29:83.
14. Villa AE, Guzman LA, Poptic E, Labhasetwar V, Dì’¯usa S, Levy RJ, DiCorleto P, Topol EJ. Local Delivery of Antisense c-myb for Prevention of Neointimal Proliferation after Balloon Arterial Injury. Circulation 1993; 88:I-81.
15. Guzman LA, Villa AE, Forudi F, Rothlein R, Topol EJ. Effect of Anti-CD18 Adhesion Glycoprotein Monoclonal Antibody on Restenosis Following Balloon Angioplasty in the Rabbit Atherosclerotic Model. J Am Coll Cardiol, 1994; February: 20A.
16. De Marchena EJ, Chakko S, Fernandez P, Villa AE, Thurer R, Kessler K, Myerburg RJ. Cardioverter/Defribrillator improves survival of patients with severe left ventricular dysfunction. Cardiology Board Review 1991; 9:96-105.